ATARA BIOTHERAPEUTICS INC's ticker is ATRA and the CUSIP is 046513107. A total of 126 filers reported holding ATARA BIOTHERAPEUTICS INC in Q4 2018. The put-call ratio across all filers is 0.28 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $52,491 | +8.4% | 35,467 | +18.0% | 0.00% | – |
Q2 2023 | $48,408 | -37.6% | 30,067 | +12.4% | 0.00% | – |
Q1 2023 | $77,567 | +0.8% | 26,747 | +14.0% | 0.00% | – |
Q4 2022 | $76,988 | -0.0% | 23,472 | +15.1% | 0.00% | – |
Q3 2022 | $77,000 | -37.9% | 20,396 | +27.3% | 0.00% | – |
Q2 2022 | $124,000 | -22.5% | 16,023 | +57.9% | 0.00% | – |
Q4 2021 | $160,000 | -45.6% | 10,146 | -38.3% | 0.00% | – |
Q3 2021 | $294,000 | -1.0% | 16,452 | -13.9% | 0.00% | – |
Q2 2021 | $297,000 | -33.0% | 19,119 | -38.1% | 0.00% | – |
Q1 2021 | $443,000 | -26.5% | 30,877 | +0.5% | 0.00% | – |
Q4 2020 | $603,000 | +321.7% | 30,723 | +178.9% | 0.00% | – |
Q3 2020 | $143,000 | -14.9% | 11,014 | -4.7% | 0.00% | – |
Q2 2020 | $168,000 | -66.5% | 11,560 | -8.1% | 0.00% | – |
Q1 2019 | $501,000 | +121.7% | 12,585 | +93.4% | 0.00% | – |
Q4 2018 | $226,000 | -60.4% | 6,507 | -52.8% | 0.00% | -100.0% |
Q3 2018 | $570,000 | +31.6% | 13,777 | +17.1% | 0.00% | – |
Q2 2018 | $433,000 | +102.3% | 11,765 | +114.2% | 0.00% | – |
Q1 2018 | $214,000 | – | 5,492 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Antipodean Advisors LLC | 1,000,000 | $1,610,000 | 11.42% |
Redmile Group, LLC | 6,048,123 | $9,737,478 | 0.37% |
Baupost Group | 9,773,616 | $15,736 | 0.28% |
JOSH ARNOLD INVESTMENT CONSULTANT, LLC | 170,000 | $273,700 | 0.27% |
MAVERICK CAPITAL LTD | 6,290,713 | $10,128,048 | 0.22% |
683 Capital Management, LLC | 1,000,000 | $1,610,000 | 0.12% |
WASATCH ADVISORS LP | 8,283,981 | $13,337,209 | 0.08% |
PACIFIC HEIGHTS ASSET MANAGEMENT LLC | 525,000 | $845,250 | 0.08% |
STALEY CAPITAL ADVISERS INC | 750,000 | $1,207,500 | 0.06% |
XTX Topco Ltd | 136,841 | $220,314 | 0.04% |